XML 55 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheets Details
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheets Details
3.
Balance Sheet Details

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following as of December 31, (in thousands):

 

 

 

2022

 

 

2021

 

Tax receivable

 

$

1,506

 

 

$

104

 

Prepaid R&D costs

 

 

1,476

 

 

 

2,467

 

Prepaid insurance and service contracts

 

 

1,424

 

 

 

1,860

 

Interest receivable - marketable debt securities

 

 

168

 

 

 

 

Other

 

 

319

 

 

 

230

 

Total

 

$

4,893

 

 

$

4,661

 

 

Property and Equipment, Net

Property and equipment, net, consist of the following as of December 31, (in thousands):

 

 

 

2022

 

 

2021

 

Laboratory equipment

 

$

7,559

 

 

$

6,851

 

Computers, software and office equipment

 

 

512

 

 

 

489

 

Leasehold improvements

 

 

467

 

 

 

384

 

Office furniture and fixtures

 

 

123

 

 

 

126

 

 

 

 

8,661

 

 

 

7,850

 

Accumulated depreciation and amortization

 

 

(5,617

)

 

 

(4,866

)

Total

 

$

3,044

 

 

$

2,984

 

 

Depreciation and amortization expense for property and equipment for the years ended December 31, 2022 and 2021 was $0.8 million and $0.6 million, respectively.

Accrued Liabilities

Accrued liabilities consist of the following as of December 31, (in thousands):

 

 

 

2022

 

 

2021

 

Accrued R&D costs(1)

 

$

4,069

 

 

$

9,043

 

Accrued compensation

 

 

3,494

 

 

 

3,664

 

Accrued audit, tax and filing fees

 

 

1,703

 

 

 

556

 

Accrued directors and officers insurance premium
   financing obligation
(2)

 

 

926

 

 

 

 

Accrued other

 

 

1,122

 

 

 

862

 

Total

 

$

11,314

 

 

$

14,125

 

__________

(1)
Includes $99 and $250 of accrued R&D costs due to related parties as of December 31, 2022 and 2021, respectively.
(2)
Represents the remaining balance due under the Company’s insurance premium financing agreement, which is payable in equal monthly installments through May 2023 and bears interest at approximately 3.4% per annum.